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Summary
Objectives: Non-epileptic seizures (NES) present a considerable challenge in clinical
practice. This paper reviews published evidence for the reliability of a number of
procedures for the differential diagnosis of NES and epilepsy.
Methods: Papers identified from MEDLINE and PsychInfo Databases (1980—2001) and
additional hand searches were independently reviewed using methods for evaluating
evidence in systematic reviews [Liddle, J., Williamson, M. Irwig, L. Method for
evaluating research guideline evidence. New South Wales Department of Health;
1996 [State Health publication no. (CEB) 96—204]; SIGN. An introduction to SIGN
methodology for the development of evidence based clinical guidelines. Scottish
Intercollegiate Network; 1999]. Included studies had to have an NES group and a
control group of people with epilepsy (each n  10), allocated using EEG linked video-
recording of concurrent behaviour, and sensitivity and specificity values had to be
stated or be calculable.
Results: Thirty-three papers were identified, of which 13 satisfied criteria. Excluded
studies are briefly described. Those retained comprised a range of procedures [seizure
induction, MMPI assessment, physiological assessment (prolactin, SPECT), pre-ictal
pseudosleep, and ictal/post-ictal characteristics]. No procedure emerged with both
high sensitivity and specificity and adequately replicated findings, although high
levels of specificity were more commonly reported than high levels of sensitivity. This
suggests that procedures were generally better at excluding a possible diagnosis.
Conclusions: No procedure attains reliability equivalent to EEG video-telemetry.
Further rigorous evaluation, using standardised and replicable methodologies, is
required. The range of symptoms presented in NES suggests that a multi-method
approach may be required. This too would require evaluation.
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Non-epileptic seizures (NES) are events resembling
epileptic attacks, but lacking their characteristic
clinical and electrographic features. They have
been referred to as ‘‘pseudoseizures’’, ‘‘hysterical
seizures’’ and ‘‘psychogenic seizures’’,1 although
the last term more properly applies to genuine
epileptic events triggered by emotion. ‘‘Non-epi-
leptic attack disorder’’ (NEAD) has also been used,2
but ‘‘non-epileptic seizures’’ is now generally pre-
ferred.
NES reportedly occur in 10—20% of patients with
presumed intractable epilepsy referred to epilepsy
centres,3 can co-occur in patients with true epilep-
tic seizures4 and can be mistaken for treatment
refractory epilepsy. It is important to distinguish
between NES and epilepsy because patients mis-
diagnosed may be given anti-epileptic drugs (AEDs),
which may worsen NES5 and may have frequent and
unnecessary hospital admissions.6 Also, if NES is not
recognised, the patient may not receive the treat-
ment required to alleviate their seizures.
NES and epilepsy are diagnoses informed by
patient report, history, observation (mainly by
family members but sometimes by clinicians), neu-
rophysiological investigation, and other types of
test or assessment. New methods of diagnosing
NES and epilepsy are continually being developed,
yet despite its high prevalence, the literature on
differential diagnosis is relatively small. This paper
reviews this literature and reports sensitivity and
specificity data for each diagnostic approach.Criteria for inclusion of studies
All studies included met formal criteria based on the
Method for Evaluating Research Guideline Evidence
(MERGE7), also used by the Scottish Intercollegiate
Guidelines Network8 for evaluating evidence in sys-tematic reviews. Criteria were adjusted, where,
necessary, to be applicable to the purpose of the
review. The criteria used were that;1. A study included both a group of people with NES
and a control group of people with epilepsy.2. Participants were allocated to experimental
groups using the ‘‘gold standard’’ method of
diagnosis–—EEG linked to video-recording of con-
current behaviour, to register the association of
any epileptiform abnormalities with observed
behaviour.93. There was a minimum sample size of 10 partici-
pants per group.4. Data on sensitivity and specificity values for each
diagnostic test, or adequate information to allow
this to be calculated, was available. Sensitivity
referred here to a test’s ability to identify accu-
rately persons with NES, while specificity
referred to the test’s ability to exclude persons
who do not have NES.5. Where induction procedures were used, the
evoked seizure should be typical of previous
seizures.
Research papers were identified for inclusion by
searching MEDLINE and PsychInfo databases from
1980 to 2001. Additional hand searches were under-
taken of references included in obtained papers.
Thirty-three papers were identified for possible i-
nclusion. These were independently reviewed, and
13 studies were found which satisfied all of the a-
bove criteria.Papers not included
Reasons for exclusion are provided at the end of this
paper (Appendix A). Nevertheless, these studies
described some interesting methods. Alhalabi and
Verma10 suggested that eye opening during seizures
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Table 1 Summary characteristics of studies meeting inclusion criteria.
Study No. of subjects
in each group
Design Method of
diagnosis used
Results–—sensitivity and
specificity for NES (%)
Gender/age distribution
if available
Regional /local
centre
Barry et al.29 NES = 36,
ES = 22,
both = 11
Experimental procedure–—
induction; ES group: temporal
lobe, frontal lobe seizures;
participants taught to start and
stop seizures under hypnosis
Hypnotic
seizure
induction
Sens = 77, Spec = 95 17 males, 52 females;
age range = 19—59 years
Bell et al.41 NES = 13,
ES = 31
Experimental procedure–—
psychometric; ES group:
complex partial seizures; NES
group: not stated whether
also have ES
Ictal cognitive
assessment
Memory testing:
Sens = 54, Spec = 100
ES group: age range =
7—52 years; mean = 27.4
years; S.D. = 12.7; NES
group: age range = 12—54
years; mean = 33.1 years;
S.D. = 14.3
Benbadis et al.39 NES = 18,
ES = 39
Observational study; ES group:
tonic clonic, complex partial
seizures; NES group: only NES
Pre-ictal
pseudosleep
Per patient: Sens = 56,
Spec = 100; per seizure:
Sens 23, Spec = 100
ES group: 17 males,
22 females; age range =
16—60 years; mean =
35 years; S.D. = 11.8;
NES group: 4 males,
14 females; age range =
18—48 years; mean =
32.6 years; S.D. = 8.5
Derry et al.35 NES = 24,
ES = 115
Experimental procedure–—
psychometric study; ES group:
simple and complex partial,tonic
clonic seizures; NES group: ES also
MMPI-II Sens = 92, Spec = 94 ES group: 54 males,
61 females; NES group:
11 males, 13 females;
age range overall =
18—57 years
Ehsan et al.36 NES = 14,
ES = 36
Experimental procedure–—
physiological; ES group: tonic
clonic, complex partial, simple
partial; NES: unclear whether pure
NES; blood analysed at various
times after seizure
Capillary
prolactin
levels
Sens = 93, Spec = 69 Ratio of females:males =
1.5:1; age range 6—61
years; mean = 33 years
Ettinger et al.38 NES = 11,
ES = 11
Experimental procedure–—
physiological; ES group: impaired
consciousness seizures only; NES
group: not stated whether also have
ES; compared postictal and interictal
SPECT
Post-ictal
SPECT
Sens = 73, Spec = 64 5 males, 17 females
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Table 1 (Continued )
Study No. of subjects
in each group
Design Method of
diagnosis used
Results–—sensitivity and
specificity for NES (%)
Gender/age distribution
if available
Regional /local
centre
Ettinger et al.43 NES = 23,
ES = 16
Observational study;
ES group: tonic clonic
or focal seizures with
secondary generalisation;
NES group: NES only
Post-ictal
symptoms
No headache: Sens = 96,
Spec = 38; no fatigue:
Sens = 87, Spec = 56:
confusion alone: Sens = 13,
Spec = 88; no symptoms:
Sens = 52, Spec = 100,
other: Sens = 17, Spec = 88
ES group: 5 males,
11 females; age range =
18—55 years; mean =
39 years; NES group:
4 males, 19 females;
age range = 24—59
years, mean = 43 years
Gates et al.40 NES = 25,
ES = 25
Observational study;
ES group: tonic clonic;
NES group: ES also
Ictal
characteristics
Absence of upper and lower
extremity in-phase movements
and absence of vocalisations at
beginning or end of seizure:
Sens = 96, Spec = 96; absence
of upper and lower extremity
in-phase movements, forward
pelvic thrusting, absence of
whole body rigidity:
Sens = 92, Spec = 100
ES group: 18 males;
age range 16—59
years; mean = 32 years;
32 females; age
range 19—44 years;
mean = 29 years; NES
group: 5 males;
age range 16—38
years; mean = 28
years; 20 females;
age range 21—60 years,
mean = 37 years
Geyer et al.42 NES = 100,
ES = 111
Observational study;
ES group: temporal lobe,
frontal lobe, tonic clonic
seizures; NES group:
not stated whether also
have ES
Pelvic thrustingSens = 26, Spec = 89;
only thrashing activity:
Sens = 78, Spec = 89
Right temporal lobe:
27 males, 23 females;
range = 18—59 years;
mean = 32.5 years;
left temporal lobe:
22 males, 28 females;
range = 11—70 years;
mean = 35.2 years;
frontal: 21 males,
29 females, range =
11—61 years; mean =
28.4 years; generalised:
NES, 28 males,
72 females; range =
11—57 years; mean =
36.8 years
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Slater et al.31 NES = 31,
ES = 41,
both = 1,
other = 6
Experimental procedure–—
induction; ES group: complex
partial, supplementary motor
seizures; NES group: majority
pure NES; neuro-psychological
testing then saline introduction
procedure
Intravenous
saline
placebo
induction
Sens = 91,
Spec = 100
ES group: male:female =
1:1; mean age = 33.9
years; S.D. = 33.9; NES
group: male:female =
2.2:1; mean age = 34.8
years; S.D. = 10.5
Vanderzant et al.34 NES = 19,
ES = 20
Experimental procedure–—
psychometric study; ES
group: tonic clonic only;
NES group: NES only
MMPI Sens = 30,
Spec = 90
Age range = 15—55 years
Varma et al.37 NES = 10,
ES = 10
Experimental procedure–—
physiological; ES group:
seizure type not stated;
NES group: NES only
HMPAO
SPECT
Sens = 70,
Spec = 80
No information
Wilkus et al.33 NES = 21,
ES = 25
Experimental procedure–—
psychometric study;
ES group: not stated;
NES group: ? NES only;
28 NES patients selected
from 150 referrals;
only 21 completed study;
neuro-psychological
test results analysed of
15 in each group,
then 3 rules devised
MMPI Sens = 90,
Spec = 80
ES group: mean age = 29.8
years; S.D. = 9.7 years;
NES group: mean
age = 28.2 years;
S.D. = 10.35 years
298 F.M. Cuthill, C.A. Espiemay be a reliable distinguishing feature. Arturo-Leis
et al.11 investigated other ictal characteristics and
King et al.12 investigated the accuracy of observa-
tional diagnoses by neurologists, unit staff and
referring clinicians. Several papers concentrated
on physiological factors, such as simultaneous ele-
vation of serum pituitary hormones and cortisol
levels,13 plasma prolactin levels,14,15 postictal
serum creatine kinase,16 the presence of cerebral
pathology17 and the role of quantitative ictal SPECT
analysis.6 Other studies described provocation
methods to elicit NES. Fariello et al.18 investigated
re-enactment of the triggering situation, Stauden-
mayer and Kramer19 described seizures elicited by
fragrances, and saline infusion has been investi-
gated by several groups.20—23 Provocation during
psychiatric interviewing,24 head-tilting proce-
dures,25 application of a tuning fork to the fore-
head26 and an alcohol soaked pad being placed on
the patient’s neck27 have also been reported. Avoid-
ance reactions of noxious or painful stimuli during a
seizure have also been suggested as a possible dif-
ferentiating factor.28Analysis of papers satisfying inclusion
criteria
Brief characteristics of each paper are summarised
in Table 1.
Seizure induction procedures
Two papers using seizure induction met criteria.
Barry et al.29 investigated the utility of hypnosis
in a three group design (epilepsy, NES, epilep-
sy + NES). HIP scores (Hypnotic Induction Profile30),
which indicate hypnotic potential, were generated
while participants underwent hypnosis. They were
then taught to provoke and terminate seizures by
imagining a split screen with ‘‘RELAX’’ on one side
and ‘‘SEIZURE’’ on the other. It was found that the
hypnotic procedure was 77% sensitive and 95% spe-
cific for NES, and that when the NES and epilep-
sy + NES groups were combined, there was a
significant difference in hypnotisability compared
to the epilepsy group.
Slater et al.31 injected intravenous saline placebo
and informed patients that this would have a greater
than 90% chance of bringing on a seizure. Patients
were also informed of the progress of the drug in
their system and what they should be feeling at
different time intervals. The induction was carried
out in a standardised way for all patients. The
procedure provoked seizures in 29 of 32 NES patients
(91% sensitivity for NES), but did not provoke sei-zures in any patient in an epileptic group (100%
specificity).
Minnesota multiphasic personality inventory
Several studies have been undertaken using the
MMPI, a personality scale which has acceptable
reliability and stability.32 One of the earliest was
by Wilkus et al.33 who assessed 21 patients with NES
and a matched group of 25 epilepsy patients. A
battery of tests was administered by psychometrists
blind to the purpose of the study. A detailed analysis
was carried out on sub-groups from each cohort, and
a set of rules, primarily concerning the Hysteria (Hs)
and Hypochondriasis (Hy) scales, was devised for
differentiating NES from epilepsy. These rules were
then applied blind to the two remaining sub-groups
to test their effectiveness in differentiating NES and
epilepsy. Significant differences were observed in
MMPI scores and score profiles, with the NES group
exhibiting a pattern of scores similar to that seen in
the conversion form of hysteria. Using the derived
rules, the MMPI achieved 90% sensitivity for NES and
80% specificity in classifying seizure type.
Vanderzant et al.34 undertook a replication of this
study, although subjects were not matched demo-
graphically. Nineteen patients with NES and 20 epi-
leptic patients with tonic-clonic seizures were
assessed, however, when the rules developed by
Wilkus et al. were applied, sensitivity for NES was
computed as 30% and specificity as 90%. In particu-
lar, Vanderzant et al. did not find hysteria to be a
typical feature of NES patients.
The discriminatory accuracy of the re-standar-
dised MMPI-2 has also been evaluated with 24 NES
and 115 epilepsy patients.35 Sensitivity for NES was
calculated at 92% and specificity at 94%, however,
these findings should be interpreted with caution
because the MMPI rules were both determined and
tested within the same sample of patients.
Physiological methods–—prolactin levels and
SPECT
One paper was identified for inclusion which inves-
tigated the diagnostic accuracy of paired capillary
prolactin measurement in 36 patients with mixed
epileptic seizure types and 14 NES patients.36 Blood
taken 15 and 75 min after a seizure yielded sensi-
tivity for NES of 93% and specificity of 69%, with no
change in prolactin levels being indicative of NES.
HMPAO SPECT has also been used in differential
diagnosis. Varma et al.37 compared 10 individuals
with NES and 10 matched controls with epilepsy. All
patients underwent SPECT scans which were ana-
lysed by an expert physician blind to other clinical
Non-epileptic seizures 299information. When a normal scan was taken as
indicative of NES, Varma et al. computed sensitivity
for NES at 70% and specificity at 80%.
Ettinger et al.38 investigated post-ictal SPECTas a
potential differentiating method using 11 NES and
11 epilepsy subjects, who experienced seizures in
which ‘‘impaired consciousness’’ was a feature.
Again, it was hypothesised that the NES group would
have normal SPECT. Abnormal SPECTwas defined as
any areas of hypoperfusion and hyperfusion which
have more or less than 15% of the uptake of adjacent
areas. Ettinger et al.’s results suggested that com-
parison of post-ictal to inter-ictal SPECT may be
useful to distinguish epilepsy from NES due to an
absence of change resulting in 73% sensitivity for
NES and 64% specificity.
Pre-ictal pseudosleep
Benbadis et al.39 studied a group of 18 NES and 39
epilepsy patients to investigate pre-ictal pseudo-
sleep (a state with the behavioural characteristics
of sleep but with EEG signs of wakefulness) as a
possible differentiating sign of NES. Pseudosleep
had to be sustained for at least 1 min before the
onset of a seizure, and results were analysed per
patient and per seizure. Analysis per patient yielded
a sensitivity of 56% for NES and a specificity of 100%,
and analysis per seizure yielded a sensitivity of 23%
and a specificity of 100%. The presence of pseudo-
sleep, therefore, appears to reliably exclude epi-
lepsy but is not a reliable presenting feature of NES.
Ictal and post-ictal symptoms
Several studies have investigated ictal or post-ictal
symptoms which may differentiate epilepsy and
NES. In a detailed early study, where many ictal
symptoms and combinations of symptoms were
explored, Gates et al.40 sourced EEG video record-
ings from a seizure library. Pseudoseizures resem-
bling tonic-clonic events in 25 patients were
compared with 25 tonic-clonic seizures. Variables
were analysed individually, and then combined. It
was found that when the absence of upper and lower
extremity in-phase movements and the absence of
vocalisations at the beginning or end of a seizure
were combined, sensitivity for NES was 96% and
specificity was also 96%. When the combination of
absence of upper and lower extremity in-phase
movements, forward pelvic thrusting and absence
of whole body rigidity was used, sensitivity for NES
was slightly lower at 92%, however specificity was
100%.
Bell et al.41 conducted ictal cognitive assessment
during apparent partial seizure events in 13 NESpatients and 31 patients with complex partial sei-
zures. Response testing alone did not differentiate
between the two groups, with impaired responsive-
ness being shown during >95% of both patients with
complex partial seizures and NES. However, memory
testing was somewhat more useful, with 50% or
greater recall emerging as the most useful criterion
(sensitivity for NES of 54%; specificity of 100%). The
authors concluded that any patient with at least 50%
recall during an event with apparent alteration of
consciousness should be suspected of having NES.
Geyer et al.42 studied pelvis thrusting as a feature
of presentation. Prolonged video EEG data on 50
consecutive patients with left temporal lobe epi-
lepsy, 50 with right temporal lobe epilepsy, 50 with
frontal lobe epilepsy, 11 with generalised epilepsy
and 100 with NES were reviewed. Two independent
investigators judged the presence/absence of pelvic
thrusting, achieving 100% reliability. When the epi-
leptic groups were considered together, the pre-
sence of pelvic thrusting was 26% sensitive for NES
and 89% specific. Where only NES patients whose
seizures comprised predominantly thrashing activity
were included, sensitivity for NES increased to 78%.
However, thrusting was more common in patients
with frontal lobe epilepsy (24%) than those with NES
(17%), suggesting that the presence of pelvic thrust-
ing does not reliably differentiate NES and frontal
lobe epilepsy.
Post-ictal symptoms have also been used to dis-
tinguish between epilepsy and NES.43 Sixteen epi-
lepsy patients and 23 NES patients were asked what
symptoms they experienced after a seizure. Several
symptom reports were suggestive of between group
differences. ‘‘No headache after seizure’’ yielded
sensitivity for NES of 96% and specificity of 38%
(calculated from Ettinger et al.’s data), ‘‘no fatigue
after seizure’’ yielded a sensitivity of 87% and a
specificity of 56%, and ‘‘confusion alone’’ was 13%
sensitive for NES and 88% specific. The experience of
no post-ictal symptoms whatsoever was calculated
to yield sensitivity for NES of 52% and specificity of
100%, while the presence of any other symptoms
yielded a sensitivity for NES of 17% and a specificity
of 88%.Discussion
This paper investigates the sensitivity and specifi-
city of various methods of diagnosing NES. Studies
published since 1980 were selected, using strict
criteria to ensure acceptable methodology. How-
ever, before considering results from the retained
studies, two observations should be made. First,
only 33 studies were found, over this 20-year period,
300 F.M. Cuthill, C.A. Espiedescribing procedures for differential diagnosis. Of
course, there are also studies of EEG video-teleme-
try, which we have to take as the ‘‘gold standard’’
criterion measure against which to judge, but the
fact remains that relatively little work has been
undertaken in this important clinical area. The
practical utility and reliability of simpler, more
available, and less expensive procedures for differ-
ential diagnosis is of importance in routine practice.
Ideally, ‘‘bedside criteria’’ or simple discriminatory
tasks or procedures would be adjuncts to video-
telemetry, which in the absence of other proce-
dures, relies upon capturing ‘‘spontaneous’’ seizureFigure 1 Sensitivity and specevents for subsequent analysis. Second, consider-
ably less than half the studies we identified met our
criteria for inclusion (13 from 33). Much of the
literature in this area is either primarily descriptive
or poorly controlled, and many studies are of very
small sample size.
We suggest that our criteria were appropriate to
address the question of diagnostic accuracy, but
were not overly rigorous, particularly in relation
to n. We selected n = 10 per group as a threshold
value. We recognise that this is a somewhat arbi-
trary minimum group size, but it is consistent with
standards of practice reviews of studies in otherificity of reviewed papers.
Non-epileptic seizures 301fields. Furthermore, most studies in fact reported
much larger samples. It must be borne in mind that
sample source, as well as sample size, may influence
results very considerably. For example, NES patients
may be recruited to a study from a regional or a local
facility. Furthermore, these patients often have
long and complex histories of care. The timing of
participation in a study may also affect results
because more straightforward cases may be dealt
with differently from difficult to diagnose or treat-
ment refractory cases.
Wide variation was found in sensitivity and spe-
cificity data and no procedure can be recommended
as comparable to the ‘‘gold standard’’ of EEG video
telemetry. Inspection of Fig. 1, which summarised
results from the 13 retained studies, shows that
greater confidence may be placed in the specificity
of the majority of tests, than in their sensitivity. No
study achieved a 100% sensitivity rate either for NES
or for epilepsy, although several reported 100%
specificity. For example, NES was not misdiagnosed
as epilepsy by post-ictal SPECT,38 and epilepsy was
not misdiagnosed as NES by saline placebo induc-
tion,31 pre-ictal pseudosleep39 or ictal memory
recall.41 However, tests were insensitive to the
correct diagnosis, with most procedures having sen-
sitivity values of less than 80%. Only one quarter of
NES patients exhibited pelvic thrusting,42 half pre-
sented with pseudosleep,39 and three-quarters
responded to hypnotic seizure induction.29 There-
fore, the absence of such symptoms or responses
could not be taken as evidence of epilepsy. Like-
wise, HMPAO SPECT and paired capillary prolactin
classified around 70% of epilepsy cases36,37 and post-
ictal SPECT only about half,38 so non-identification
by these methods could not be taken to imply NES.
Gates et al.40 reported on a wide range of observed
ictal symptoms and although they found that all
their NES patients vocalised during seizures, so
did approaching half of their epilepsy patients.
It is problematic to compare across studies for a
number of reasons. First, most studies describe dif-
ferent types of diagnostic procedure. Although there
are two papers on seizure induction, the procedures
used varied considerably29,31 and three papers uti-
lised the MMPI,33—35 but even these are not directly
comparable. It is interesting, nevertheless, that the
specificity of MMPI profiles was generally accepted
across studies,whereas sensitivity forNES dropped to
around one-third in the Vanderzant et al.34 study.
Thus there are no reliable replication data for any
study, and those that use similar procedures some-
times produce very different results. A parsimonious
conclusion may be that diagnostic procedures are
more or less reliable in making diagnoses, depending
upon the sample population.This raises a second problem, that of sampling
adequacy and comparability. Some authors do not
fully define their terminology or their understanding
ofNESorpseudoseizures. The latter, forexample, has
been taken to mean syncope, hyperventilation syn-
drome or other physical phenomena bearing a like-
ness to epilepsy. Furthermore, five of the reviewed
papers included participants with a combination of
NES andepilepsy,29,31,35,40,43 four includedonly those
with NES or epilepsy,34,36,37,39, and four did not state
their criteria in this respect.33,38,41,42 Sampling dif-
ferences were also evident across epilepsy compar-
ison groups. Six studies included combinations of
epilepsy seizure types,29,35,36,37,42,43 four used only
one type,34,38,40,41 and three did not state seizure
types.31,33,39 This may be important because a diag-
nostic test may achieve higher sensitivity and speci-
ficity when it is utilised in relation to specific seizure
physiology or semiology. Sample sizes have also been
modest, ranging from10 to 100 for theNES group, but
with 12 of the 13 retained studies having n  36
(median = 21). Smalln, combinedwithheterogeneity
within and between samples, makes any conclusion
regarding diagnostic reliability tentative.
Third, the site of the study may also have influ-
enced the type of patient selected for inclusion.
Tertiary, regional neurological centres are more
likely to see patients with intractable or previously
unrecognised cases of NES than smaller, local units,
and those whose NES is maintained by ‘‘secondary
gain’’ may not be included at all, because they may
avoid participation or fear intensive evaluation.
Once a diagnosis of epilepsy is given it is not easily
removed.44 If then, the NES is misdiagnosed as epi-
lepsy this may have both medical and psychosocial
repercussions. For example, there is the possibility of
undergoing invasive treatment for non-existent epi-
lepsy,45 the danger of taking unrequired AEDs,46 and
having to livewith psychosocial limitations (including
driving restriction) and the social stigma of epi-
lepsy.47 Furthermore, individuals with epilepsy who
also develop NES are at risk of excessive AED pre-
scription.48 Failure to identify NES also results in
psychological needs remaining undisclosed and
unmet.45 For these, among other reasons, there
has been some clinical and research interest in the
differential diagnosis of NES andepilepsy. This review
suggests that EEG video-telemetry has as yet no
reliable equivalent amongst the range of procedures
and observations which have been suggested. How-
ever, larger and better designed studies with replic-
able methodologies including well described and
homogenous comparison groups and clearly specified
experimental or observational protocolsmay demon-
strate the usefulness of some promising procedures.
Systematic studies are also required on combination
302 F.M. Cuthill, C.A. Espieapproaches, for example a serial approach to the
attempted identification or exclusion of a diagnosis
may improve sensitivity and specificity toward 100%.Appendix A. Reasons for exclusionPaper Criteria failedAlhalabi and Verma9 1, 2, 4, 5
Alving15 2
Anzola14 3
Arturo-Leis et al.11 1—4
Cohen et al.24 1, 3, 4
Dericioglu et al.20 2, 4
Drake23 1—4
Fariello et al.18 1—4
Guberman26 1, 2, 4
King et al.12 3, 4
Lancman et al.27 2
Lelliot and Fenwick17 1—4
Luther28 1, 2, 4
Rao et al.13 2—4
Sinha et al.22 1, 2, 4
Spanaki et al.6 1, 3, 4
Staudenmayer and Kramer19 1—4
Walczak et al.21 1—4
Wyllie et al.16 3, 4
Zaidi et al.25 1, 3, 4References
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